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Interest in particulate matter (PM) air pollu-
tion has been driven by epidemiologic studies
reporting adverse cardiac and respiratory
health effects [Bascom et al. 1996; Dockery
2001; U.S. Environmental Protection Agency
(EPA) 2004]. To further investigate the basis
for these epidemiologic ﬁndings, it is impor-
tant to assess individual exposures to PM and
their related health effects. Panel studies that
include indoor, outdoor, personal, and ﬁxed-
site PM monitoring can provide an impor-
tant link between the effects observed in a
population and the effects at the individual
subject level.
Panel studies often report gravimetric
measures of PM. However, current research
is focusing on the constituents of PM
(Brunekreef et al. 2005). Elemental carbon
(EC) is one component of PM that has been
associated with respiratory health effects in
children. In a 10-year study of 1,759 children,
Gauderman et al. (2004) found a strong asso-
ciation between reduced annual growth in
forced expiratory volume in 1 sec (FEV1) in
children and exposure to EC, nitrogen diox-
ide, and acid vapor. EC, measured on quartz
filters by thermal desorption, is strongly
associated with, but not identical to, “black
carbon” (BC), as measured by diffuse trans-
mittance through or reﬂectance from a Teﬂon
filter. In a recent study, Kim et al. (2004)
reported that concentrations of trafﬁc-related
pollutants (PM, BC, total nitrogen oxides,
and NO2) were associated with respiratory
symptoms in children.
EC and BC have also been associated
with cardiovascular health effects. In a study
of deﬁbrillator discharge interventions among
100 adult patients, Peters et al. (2000) found
that patients with ≥ 10 interventions experi-
enced increased arrhythmias in association
with short-term variations in BC, NO2, car-
bon monoxide, and fine particulate mass
(PM2.5). In a study of 269 elderly Boston,
Massachusetts, residents equipped with
Holter monitors, an elevated BC level was
associated with a –0.1 mm ST-segment
depression; this BC level predicted increased
risk of ST-segment depression among those
with at least one episode of that level of ST-
segment depression (Gold et al. 2005).
Furthermore, in elderly subjects in Boston,
BC increases were associated with a decrease
in ﬂow-mediated vascular reactivity (–12.6%;
O’Neill et al. 2005). These studies implicate
particles whose predominant source is trafﬁc
as a risk factor for adverse health effects.
Accumulated data suggest that PM expo-
sure may lead to pulmonary inflammation
(Gong et al. 2003; Li et al. 1996; Salvi et al.
1999). Chronic inﬂammation is a hallmark of
lung diseases such as asthma and chronic
obstructive pulmonary disease (COPD) (Gan
et al. 2004) and may be aggravated in suscepti-
ble groups by PM pollution. A noninvasive
method of estimating airway inflammation
among sensitive groups is fractional exhaled
nitric oxide (FENO). Over the last decade,
FENO has been shown to be reproducible,
inexpensive, and easy to measure serially.
FENO concentrations are also highly correlated
with other markers of airway inflammation,
such as sputum eosinophils and bronchial
hyperresponsiveness in subjects with asthma
(Jones et al. 2002). Studies have reported posi-
tive associations between FENO and ambient
PM2.5 exposures to air pollutants in commu-
nity-based studies (Adamkiewicz et al. 2004;
(Koenig et al. 2003).
Spirometry has historically been used as a
method of measuring health effects of exposure
to PM air pollution. Numerous panel studies
have examined the effects of short-term ambi-
ent PM exposure on daily lung function
[FEV1, forced vital capacity (FVC), and peak
expiratory ﬂow rate (PEF)] (U.S. EPA 2004).
Subjects with asthma tended to show small
PEF decrements for increases in PM10 and
PM2.5 concentrations, as seen in several studies
(Gielen et al. 1997; Pekkanen et al. 1997;
Peters et al. 1997; Romieu et al. 1996). 
Another measure of respiratory health,
oxygen saturation of the arterial blood (SaO2),
has been collected in panel studies. In a study
of 90 elderly subjects, Pope et al. (1999a)
found that SaO2 decreased in association with
PM10 in the Utah Valley; however, the asso-
ciation was not statistically significant and
may have been confounded by atmospheric
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We measured fractional exhaled nitric oxide (FENO), spirometry, blood pressure, oxygen saturation
of the blood (SaO2), and pulse rate in 16 older subjects with asthma or chronic obstructive pul-
monary disease (COPD) in Seattle, Washington. Data were collected daily for 12 days. We simulta-
neously collected PM10 and PM2.5 (particulate matter ≤ 10 µm or ≤ 2.5 µm, respectively) filter
samples at a central outdoor site, as well as outside and inside the subjects’ homes. Personal PM10 ﬁl-
ter samples were also collected. All ﬁlters were analyzed for mass and light absorbance. We analyzed
within-subject associations between health outcomes and air pollution metrics using a linear mixed-
effects model with random intercept, controlling for age, ambient relative humidity, and ambient
temperature. For the 7 subjects with asthma, a 10 µg/m3 increase in 24-hr average outdoor PM10
and PM2.5 was associated with a 5.9 [95% conﬁdence interval (CI), 2.9–8.9] and 4.2 ppb (95% CI,
1.3–7.1) increase in FENO, respectively. A 1 µg/m3 increase in outdoor, indoor, and personal black
carbon (BC) was associated with increases in FENO of 2.3 ppb (95% CI, 1.1–3.6), 4.0 ppb (95% CI,
2.0–5.9), and 1.2 ppb (95% CI, 0.2–2.2), respectively. No signiﬁcant association was found between
PM or BC measures and changes in spirometry, blood pressure, pulse rate, or SaO2 in these subjects.
Results from this study indicate that FENO may be a more sensitive marker of PM exposure than tra-
ditional health outcomes and that particle-associated BC is useful for examining associations
between primary combustion constituents of PM and health outcomes. Key words: asthma, black
carbon, chronic obstructive pulmonary disease, fractional exhaled nitric oxide, panel study, particu-
late matter. Environ Health Perspect 113:1741–1746 (2005). doi:10.1289/ehp.8153 available via
http://dx.doi.org/ [Online 25 August 2005]pressure (Pope et al. 1999b). Linn et al.
(1999) found no association of SaO2 and
PM10 in a panel study of 30 subjects in Los
Angeles, but DeMeo et al. (2004) found a
reduction in oxygen saturation associated
with PM2.5 in a 12-week repeated-measures
study of 28 elderly Boston residents.
Changes in cardiac measures such as blood
pressure and pulse rate, which are possible risk
factors for cardiovascular morbidity and mor-
tality, have been the focus of several PM panel
studies. A study in Germany showed a consis-
tent significant increase in blood pressure in
adults in association with increased concentra-
tions of total suspended particulates (TSP) at a
central site (Ibald-Mulli et al. 2001). Other
studies also have shown increases in blood
pressure with PM (Linn et al. 1999; Mar et al.,
2005). Pope et al. (1999a) reported an associa-
tion between PM10 and pulse rate; a 10 µg/m3
increase in the previous 1–5 day average PM10
was associated with an average increase of
0.8 beats per minute. Peters et al. (1999) found
increases in pulse rate during an air pollution
episode in Europe in January 1985. However,
Mar et al. (2005) found decreases in heart rate
associated with indoor and outdoor PM2.5 and
PM10.
Therefore, based on the literature, there is
some suggestion of associations between PM
and changes in FENO, spirometry, SaO2,
blood pressure, and pulse rate. To determine
whether changes in these health endpoints
were associated with residential and personal
PM and BC exposures, we conducted a panel
study in Seattle, Washington, of 16 older sub-
jects with COPD and/or asthma. This
research was part of a multicity panel study
designed to evaluate geographical differences
in PM and cardiorespiratory health effects
due to PM exposure. The study was con-
ducted in New York City and Seattle. Seattle
was chosen because it is known to have
elevated wood smoke levels in winter. Our
primary hypothesis was that airway inﬂamma-
tion in individuals with asthma and/or
COPD would be associated with PM air pol-
lution and BC, a measure shown to represent
elemental carbon.
Materials and Methods
PM exposures and health effects were measured
in this panel study of susceptible subjects in
Seattle during the winter of 2002–2003. The
study included 16 individuals with physician-
diagnosed asthma, COPD, or asthma and
COPD. Those individuals diagnosed with both
asthma and COPD were grouped under
COPD. A seventeenth subject (#2) did not par-
ticipate in the full study period and was not
included in the analyses. The health outcomes
measured during the study were FENO, spiro-
metry, exhaled breath condensate, pulse oxime-
try, heart rate, blood pressure, symptoms, and
medication use. Exhaled breath condensate and
symptoms are not reported here. We collected
PM2.5 and PM10 Harvard Impactor (HI; Air
Diagnostics and Engineering, Inc., Naples,
ME) 24-hr ﬁlter samples simultaneously at a
central outdoor site, as well as outside and
inside the subject’s home. Marple Personal
Environmental Monitors for PM10 (MPEM10;
MSP Corporation, Shoreview, MN) were worn
to record personal exposure. We subsequently
analyzed the ﬁlters for mass, light absorbance to
estimate BC, and trace elemental compositions
via X-ray ﬂuorescence. Only mass and BC are
reported here.
Study subjects. The participants were
recruited from a community in north Seattle,
ranged from 60–86 years of age, and were
nonsmokers living alone or with other non-
smokers. Each subject in the panel was asked
to participate for a 12-day monitoring session.
Approximately 75% of the subjects were pre-
scribed inhaled corticosteroid therapy, and
two were prescribed a leukotriene receptor
antagonist (montelukast). Both of these anti-
inﬂammation medications have been shown to
prevent increases in FENO in atopic subjects
with asthma (Jones et al. 2002; Piacentini
et al. 2002). The remaining subjects were
prescribed only inhaled albuterol as needed.
Subjects ﬁlled out a questionnaire to describe
their medical, residential, and occupational
history before enrollment in the study. A sec-
ond questionnaire was administered daily dur-
ing the study period to record typical physical
activity, time spent outdoors, home behavior,
travel, and daily medication use. All subjects
read and signed a consent form approved
by the University of Washington Human
Subjects Ofﬁce. 
Offline FENO. Exhaled breath was col-
lected according to American Thoracic Society
recommendations for offline measurement
(Slutsky et al. 1999); however, we collected
only one sample per subject visit during the
late morning of each day. Previous replicate
measures with the same collection devices
showed good agreement. The sample was col-
lected daily in the subjects’ homes for up to
12 consecutive days. We collected exhaled
breath before taking lung function measure-
ments because deep inspirations may affect
NO concentration (Deykin et al. 1998), and
subjects were asked not to eat 1 hr before col-
lection. The subjects were instructed to inhale
to nearly total lung capacity and exhale
through an offline collection device (Model
280i; Sievers Ionics, Boulder, CO). The sub-
jects repeated this inhalation–exhalation cycle
twice, and the third breath was collected into a
nonreactive, self-sealing Mylar-like balloon.
Subjects maintained a constant flow rate
(0.35 mL/sec), inhaled NO-free air during the
entire procedure, and exhaled with sufﬁcient
pressure (13 cm H2O) to close the epiglottis
and prevent contamination of the airway NO
sample by nasal NO. We collected samples at
the same time of day (late morning) at their
residences. NO was measured within 24 hr of
collection using a chemiluminescent nitrogen
oxide (NOx) monitor (model 280i; Sievers
Ionics). Multiple NO concentrations from
Mylar-like bags varied by < 2 ppb over a 24-hr
period, consistent with that found by Jobsis
et al. (1999). The monitor was calibrated daily
using zero air and 45 ppm NO.
Lung function and SaO2. Spirometry was
performed according to American Thoracic
Society recommendations (Crapo et al.
1995). The subjects performed the spirometry
maneuvers during the technician visit. We
measured FEV1, FVC, FEV1/FVC, PEF, and
MEF (mid-expiratory flow). We recorded
maximum forced expiratory maneuvers using
diaphragm spirometers (SMI III Spirometer;
Spirometrics Inc., Gray, ME). Subjects per-
formed the maneuvers while sitting. Each
subject was asked to perform three satisfactory
blows, defined as FVC and FEV1, agreeing
within 5% and a forced expiratory time
exceeding 6 sec. No more than five blows
were attempted. Height, weight, age, sex, and
ethnicity were determined from subject’s
questionnaire responses. Spirometers were
kept at the subject’s home and calibrated just
before the test session using 3-L calibration
syringes (Ohio Medical Products; Airco, Inc.,
Madison, WI). The use of respiratory medica-
tions was recorded daily. Three times daily
(morning, mid-day, and evening) the subjects
sat at rest and placed the sensor of a pulse
oximeter (Nellcor Model N-20P; Nellcor,
Pleasanton, CA) on the left index finger.
Date, SaO2, and pulse rate were recorded.
Cardiac measurements. Blood pressure
was recorded, using the left arm while at rest,
during the technician visits. The blood pres-
sure cuffs (AND UA-767; A&D Medical,
Milpitas, CA) were calibrated before and after
the study period. Any cardiac medications
used were recorded daily.
PM mass monitoring. We collected
24-hr PM2.5 and PM10 measurements during
each 12-day session inside and outside the
subjects’ residences and at a central agency site
(Lynnwood) using HIs. Radiance Research
(Seattle, WA) nephelometers provided contin-
uous data on ﬁne particles, comparable to PM1
(Liu et al. 2002). The indoor and outdoor PM
concentrations were measured with single-stage
inertial HIs and 37-mm Teflon filters for
PM10 and PM2.5. One HI2.5–HI10 pair was
located inside each home in the main activity
room and connected to a pump (SP 280, Air
Diagnostics Inc.). Another HI2.5–HI10 pair
was located outside each home and connected
to a pump (SP 280). The on and off ﬂow rates
were calibrated and recorded daily with a
rotameter (150-nm Tube 604; Cole-Parmer
Jansen et al.
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sampling periods were for 24 hr (approxi-
mately 1100 hr to 1100 hr) at a ﬂow rate of
10 L/min. Our research group has previously
evaluated the performance of continuous PM
monitors (nephelometers) and HIs used in the
context of a panel study (Liu et al. 2003).
Simultaneous data also were collected with
a MPEM10 during the study period (24 hr for
12 consecutive session days). The MPEM10 was
connected to a personal pump (400S: BGI,
Inc., Waltham, MA) with a mass flow con-
troller operated at 4 L/min. Each subject carried
an MPEM10 in the breathing zone for 24 hr,
except while sleeping or showering. The moni-
tor was attached to the shoulder strap of either a
backpack or a fanny pack that contained the air
pump. When the monitor was not worn, it was
placed at an elevation of 3–5 ft (e.g., on a table)
close to the subjects. Field technicians visited
the subjects daily to calibrate the pumps with a
rotameter and to record on and off ﬂow rates
and change samplers.
We weighed the filters before and after
sample collection for particle mass concentra-
tion. All ﬁlter weights were measured in either
duplicate or triplicate using an electronic ultra-
microbalance (UMT2: Mettler Toledo,
Greifensee, Switzerland). The ﬁlters were equi-
librated for at least 24 hr before weighing. We
performed both equilibration and weighing
inside a controlled environmental chamber
with constant relative humidity (34.7oC ±
2.5%) and temperature (22.4 oC ± 1.9%)
(Allen et al. 2001). Standard protocols included
the use of ﬁeld blanks, ﬁlter-lot blanks, labora-
tory blanks, and externally certiﬁed standard
weights for all gravimetric analyses for quality
assurance and quality control purposes. Relative
humidity, outdoor temperature, NO, and NO2
concentrations were monitored continuously at
the Beacon Hill central site by the Washington
State Department of Ecology.
Black carbon measurements. We estimated
BC, a measure shown to represent EC from
motor vehicles and woodstoves in Seattle
(Larson et al. 2004), using an integrated plate
reader (Lin et al. 1973). It is generally agreed
that the major contributor to light absorption
by airborne particles is BC, and levels of BC
can easily be measured by this nondestructive
optical technique. The method derives absorp-
tion from the change in light transmission
through a Teﬂon ﬁlter on which particles have
been collected. We analyzed the filters from
the HIs for BC (wavelength of 525 nm) after
the mass measurements. The integrated plate
reader was re-zeroed with a blank filter
between measurements. The light absorption
coefficient, bap, was computed using the
amount of light transmitted through this
exposed filter, the amount transmitted
through the same ﬁlter before sampling, and
the volume of air that passed through the
ﬁlter. We used a previously derived association
between bap and EC in Seattle to quantify the
BC concentrations (Larson et al. 2004).
Statistical analysis. We hypothesized that
increases in PM2.5 and BC are associated with
increases in FENO. We analyzed within-
subject, within-session associations between
FENO and air pollution metrics using a linear
mixed effects model with random intercept,
controlling for age, relative humidity, and
temperature. Subjects were stratiﬁed by health
status in the FENO, spirometry, and SaO2
analyses. We put use of cardiac medications
into the model as an interaction term for the
blood pressure and pulse rate analyses. The
model included terms for within-subject,
within-session (12-day monitoring period)
effects; within-subject, between-session
effects; the confounding variable of tempera-
ture; and relative humidity. Our primary
interest was the within-subject, within-session
effects of PM2.5 and BC on FENO levels. Our
numerous exploratory analyses, the within-
subject, within-session effects of PM2.5,
PM10, and BC on spirometry, SaO2, blood
pressure, and pulse rate required use of the
Bonferroni test for multiple comparisons. The
Bonferroni test indicated a value of p <
0.0001 was significant. Therefore, for these
analyses we chose p < 0.0001 as our criteria
for statistical significance. We used STATA
software (Stata Corp., College Station, TX).
The model used was as follows:
E[Y] = B0 + bi + B1(Xid – X
–
i) + B2X
–
i
+ B3medi + B4medi × (Xid – X
–
i)
+ B5rh + B6temp, [1]
where Xidis the PM2.5 reading for individual i
on day d; X
–
i is the mean PM2.5 reading for a
subject; and medi is an indicator for medica-
tion use (constant for each subject ). 
Results
Subject characteristics. Characteristics of the
16 subjects are given in Table 1. On average,
the subjects spent 88% of their time indoors
at home, 3% of their time in transit, and 9%
of their time indoors away from home. Four
subjects reported having received both a doc-
tor’s diagnosis of asthma and of COPD.
Airborne concentration measurements. The
measured concentrations and interquartile
ranges of PM10, PM2.5, and BC are presented
in Table 2 for all the subjects, for the 7 subjects
with asthma alone, and for the 9 subjects with
COPD. At the ﬁxed-site monitor, the overall
24-hr average PM2.5 was 14.0 µg/m3, the 24-hr
minimum was 1.3 µg/m3, and the 24-hr maxi-
mum was 44 µg/m3. At the same site the over-
all 24-hr average PM10 was 18.0 µg/m3, the
24-hr minimum was 2.5 µg/m3, and the 24-hr
Fractional exhaled nitric oxide and black carbon
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Table 1. Subject characteristics of the 16 study participants.
Percent predicted Mean FENO Group mean Medication
Health Subject Age Sex FEV1 FEV1 (ppb) FENO (ppb) use
Asthma 1 83 F 1.35 82 8.1 ± 3.1 19.2 CS,B
5 85 F 1.24 79 9.7 ± 5.6 CS,I,M
6 75 M 2.38 72 26.8 ± 10.9 CS,B
9 62 F 2.07 82 19.4 ± 2.1 CS,B
14 71 F 2.7 117 26.4 ± 6.9
15 86 M 1.46 66 32.9 ± 8.4 CS
17 60 F 1.99 85 11.3 ± 3.1
COPD/asthma 3 73 M 0.85 42 10.8 ± 4.8 16.5 I,B
4 79 M 1.17 37 10.5 ± 4.4 CS,B
8 77 F 1.95 52 10 ± 4.1 CS,B
11 75 M 1.6 61 33.3 ± 14.7 CS,B,I
12 76 F 0.74 39 11.2 ± 6.1 CS,M
COPD 7 76 M 1.95 56 24 ± 10 25.4
10 76 F 0.78 43 14.4 ± 8.3 CS,B
13 78 M 2.41 83 24.4 ± 8.9 B
16 74 F 0.57 27 54.3 ± 28.6 CS
Mean 75 1.6 64 20.5
Abbreviations: B, beta-agonist; CS, corticosteroid; I, ipratropium bromide; M, montelukast. 
Table 2. Mean (interquartile range) daily residential airborne concentration measurements (µg/m3) for all
subjects during the study period.
Pollution Monitoring location All subjects Asthma (n = 7) COPD (n = 9)
PM2.5 Indoor 7.29 (4.05) 7.25 (5.72) 7.33 (3.18)
Outdoor 10.47 (8.87) 8.99 (7.55) 11.66 (6.71)
PM10 Indoor 11.93 (6.93) 12.54 (10.19) 11.45 (4.56)
Outdoor 13.47 (9.53) 11.86 (8.77) 14.76 (6.14)
Personal (Marple PEM) 23.34 (20.72) 26.88 (20.08) 19.91 (19.94)
BC Indoor 1.34 (1.12) 1.21 (1.12) 1.45 (1.11)
Outdoor 2.01 (1.68) 1.83 (2.22) 2.15 (1.31)
Personal (Marple PEM) 1.64 (2.05) 1.59 (2.38) 1.69 (1.78)
Interquartile range (75th percentile – 25th percentile). Values for PM2.5 and PM10 are given as change per 10 µg/m3; val-
ues for BC are given as change per 1 µg/m3. maximum was 51 µg/m3. The overall 24-hr
average BC was 7.2 µg/m3, the 24-hr mini-
mum was below detection limits, and the
24-hr maximum was 2.6 µg/m3.
Exhaled NO. A total of 179 midday
breath samples were collected during the
12-day monitoring periods. Average FENO
levels are shown in Table 3. The mean FENO
levels were higher for those with COPD
(25.4 ppb) than for those with asthma
(19.2 ppb) or COPD and asthma (16.5 ppb).
In those subjects with asthma, a 10 µg/m3
increase in outdoor PM2.5 and PM10, relative
to each subject session average, was associated
with a 4.2 ppb [95% conﬁdence interval (CI),
1.3–7.1; p = 0.004) and 5.9 ppb (95% CI,
2.9–8.9; p = 0.000) increase in FENO, respec-
tively. There was no association between
FENO and the 24-hr measures of indoor
PM2.5 or PM10. A 1 µg/m3 increase in out-
door, indoor, and personal BC, relative to
each subject session average, was associated
with a 2.3 ppb increase in FENO (95% CI,
1.08–3.57; p = 0.000), a 4.0 ppb increase in
FENO (95% CI, 2.02–5.91; p = 0.000), and a
1.2 ppb increase in FENO (95% CI,
0.17–2.22; p = 0.02), respectively (Table 3).
No signiﬁcant association was found between
PM or BC and changes in FENO in subjects
with COPD. The effect levels and conﬁdence
intervals are given in Table 3.
SaO2, blood pressure, and pulse rate. No
associations were observed between air pollu-
tion and SaO2, blood pressure, or pulse rate
in this study. 
Discussion
This study showed an association between
FENO in elderly subjects with asthma and
indoor and outdoor BC. Increases in FENO
also were associated with outdoor PM10 and
PM2.5 in these same subjects. Results of this
study are consistent with our earlier study of
children with asthma who were not on corti-
costeroid therapy (Koenig et al. 2003). That
study showed an increase of approximately
4 ppb FENO associated with a 10 µg/m3
increases in indoor, outdoor, personal, and
central-site PM2.5 in Seattle. Finding a similar
magnitude of response in the two different
groups (children and elderly with asthma)
strengthens the importance of this finding.
Results of the present study also are consistent
with other earlier studies in Seattle showing
that hospitalizations for asthma (Sheppard
et al. 1999) as well as increases in asthma
symptoms and increased use of rescue med-
ications (Yu et al. 2000; Slaughter et al. 2004)
are associated with ﬁne particles in Seattle.
Our data suggest that exposure to PM10
may play an important role in asthma exacer-
bation. This significant association between
FENO and PM10 was not surprising, especially
for subjects with asthma that have narrowed
airways, as the thoracic coarse particles deposit
preferentially in the larger bronchial airways
and these airways may be the ones with the
greatest inflammation potential (U.S. EPA
2004). The observed association is supported
by studies that have linked PM10 to pul-
monary inflammation in animal models (Li
et al. 1996) and the induction of inducible
nitric oxide synthase in human bronchial
epithelial cells (Martin et al. 1997).
Other studies (Steerenberg et al. 1999;
Tunnicliffe et al. 2003; van Amsterdam et al.
1999) have also reported positive associations
between FENO and ambient exposures to air
pollutants in community-based studies.
Adamkiewicz et al. (2004) reported that an
increase in the 24-hr average PM2.5 concentra-
tion of 17.7 µg/m3 was associated with a
1.45 ppb increase in FENO in elderly subjects
with asthma and COPD in a panel study in
Steubenville, Ohio. Fischer et al. (2002)
reported a 1-day and 2-day lag association
between FENO and PM10, black smoke, and
NO. In contrast, no increase in FENO was
seen in adult subjects with asthma after expo-
sure to concentrated coarse particles (Gong
et al. 2003) or ultraﬁne particles (Pietropaoli
et al. 2004). Several controlled ozone exposure
studies have assessed FENO in atopic subjects
with asthma (Newson et al. 2000; Nightingale
et al. 1999) and healthy subjects (Olin et al.
2001), but none has found an association.
We found that FENO was associated with
PM air pollution in study participants with
asthma but not those with COPD. It is inter-
esting that five of the seven subjects with
asthma were using inhaled corticosteroids,
which has been associated with mitigation of
eNO in air pollution studies (Koenig et al.
2003) and clinical settings (Deykin et al.
1998). This finding contrasts with that of a
study of elderly subjects by Adamkiewicz et al.
(2004) that found a PM2.5 response in subjects
with COPD but not asthma, although there
was some overlap in the study population and
medications were not recorded. In our study,
levels of FENO, on average, were higher in
COPD than asthma subjects. Exhaled NO in
stable COPD has been found to be lower than
in nonsmoking asthmatics (Kharitonov et al.
1995), but patients with unstable COPD have
higher NO levels than ex-smokers with COPD
(Maziak et al. 1998).
BC may more closely identify the sources
of PM than standard measures of mass con-
centration. The contribution of BC to total
PM varies geographically and temporally due
to the distribution of the combustion sources
that produce BC. Although BC is a major
component of diesel exhaust, it is also a major
component of particles produced by burning
vegetation (Conny and Slater 2002; Hobbs
et al. 2003; Mayol-Bracero et al. 2002; Posfai
et al. 2004). Recent source apportionment
studies in Seattle found that burning vegeta-
tion and mobile sources are major contribu-
tors to PM2.5 (Maykut et al. 2003) and that
burning vegetation is the dominant contribu-
tor to variations in the day-to-day BC in the
winter (Larson et al. 2004). Burning vegeta-
tion, and to a lesser extent, mobile sources,
may therefore be responsible for the observed
increases in FENO associated with BC.
It is somewhat surprising that we did not
ﬁnd an association between standard spirome-
try measures and association with PM2.5,
PM10, and BC. An earlier study completed in
Seattle during the wood-burning season
(Koenig et al. 1993) showed that spirometry,
speciﬁcally FVC and FEV1, decreased in asso-
ciation with increases in particulate matter air
pollution in children with asthma. Another
study, in Vancouver, British Columbia
Canada, showed a slight but not statistically
significant decrease in daily FEV1 change in
subjects with COPD was associated with
increase in PM2.5 (Brauer et al. 2001). In
three separate longitudinal diary studies,
decreases in PEF were shown to be associated
with increased levels of PM2.5 (Schwartz and
Neas 2000).
Our exploratory hypotheses were that
increases in PM2.5 and BC are associated with
decreases in spirometry (FEV1, MEF) and
SaO2 and with increases in blood pressure and
pulse rate. In our study, no signiﬁcant associa-
tions were seen between these health measures
and PM2.5, PM10, or BC (indoor, outdoor,
personal). Some studies have found that PM10
and PM2.5 both appear to affect lung function
Jansen et al.
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Table 3. Associations between FENO (ppb) and 24-hr average PM2.5 and PM10 (µg/m3) in subjects with
asthma and COPD. 
Asthma (n = 7) COPD (n = 9)
Pollution Location Bp -Value 95% CI Bp -Value 95% CI
PM2.5 Indoor 3.69 0.10 –0.74 to 8.12 –0.35 0.92 –7.45 to 6.75
Outdoor 4.23 0.004* 1.33 to 7.13 3.83 0.19 –1.84 to 9.49
PM10 Indoor 3.81 0.11 –0.86 to 8.50 2.19 0.45 –3.48 to 7.87
Outdoor 5.87 0.000* 2.87 to 8.88 4.45 0.12 –1.11 to 10.01
Personal 0.66 0.29 –0.56 to 1.88 0.17 0.85 –1.61 to 1.96
BC Indoor 3.97 0.000* 2.02 to 5.91 1.16 0.32 –1.14 to 3.45
Outdoor 2.32 0.000* 1.08 to 3.57 1.81 0.21 –1.00 to 4.61
Personal 1.20 0.02* 0.17 to 2.22 0.62 0.33 –0.62 to 1.86
Values for PM2.5 and PM10 are given as change per 10 µg/m3; values for BC = are given as change per 1 µg/m3.
*Statistically signiﬁcant.in asthmatics (U.S. EPA 2004); however,
many of the studies experienced higher mean
PM concentrations (in the range of 50 µg/m3)
than were experienced by subjects in this
study. The lack of significant associations
between SaO2 and PM has also been observed
in other studies (Linn et al. 1999). In addi-
tion, no signiﬁcant associations were observed
between blood pressure and pulse rate and
PM2.5, PM10, and BC in this study. This is in
contrast to studies that have reported increases
in blood pressure (Ibald-Mulli et al. 2001;
Linn et al. 1999; Mar et al. 2005) and pulse
rate (Peters et al. 1999; Pope et al. 1999a)
with exposure to PM. Our study results are
consistent with those of a larger panel study in
Seattle (Mar et al. 2005), but that study did
see minor decreases in pulse rate in healthy
subjects. Yet another study did find some
changes in ectopic beats in subjects with
COPD (Brauer et al. 2001). To our knowl-
edge the present study is the ﬁrst air pollution
study simultaneously exploring FENO, spirom-
etry, and cardiac outcomes. It appears that
FENO is more sensitive to changes in PM2.5,
PM10, and BC than the other outcomes. This
ﬁnding emphasizes the importance of includ-
ing noninvasive, sensitive measures of health
outcomes in panel studies.
The intensive monitoring of health effects
and PM metrics in this study of susceptible
individuals provides better estimates of actual
exposures than epidemiologic data based on
PM2.5 at a central site. There are, however,
several limitations to this study. Relatively
small numbers of subjects in each patient
group (asthma, COPD, and those diagnosed
with asthma and COPD) were monitored
due to time constraints and technician avail-
ability. The same constraints also limited our
ability to collect replicate NO measurements
at a single time point. Subjects with COPD
have difficulty performing spirometry. Also,
relatively low ambient PM concentrations
were experienced during the study period.
That there were weaker associations between
FENO and personal PM or BC may be
explained by small sample air volumes, espe-
cially for the 4 L/minute personal PM10 sam-
ples, and the higher relative measurement
error for these samples.
In conclusion, these data implicate com-
bustion-derived PM, as measured by light
absorption coefficient primarily from wood
burning, as being associated with airway
inflammation in adult subjects with asthma.
Further, these data support the fact that FENO
is a relatively simple, noninvasive measure to
explore the mechanisms responsible for respi-
ratory effects in air pollution epidemiologic
field studies. Further research on susceptible
populations is needed to understand the asso-
ciation between combustion-derived PM and
airway inﬂammation.
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